MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
|---|---|---|
| New | Alfentanil-hameln | |
| New | Andexxa | |
| New | Camzyos | |
| New | Exarane and Exarane Forte | |
| New | Frequent Flyer Immunity Boost | |
| New | Lithium Carbonate Extended-Release Tablets, USP (Rising) | |
| New | Nurtec ODT | |
| New | Padcev | |
| New | Pirfenidone Sandoz | |
| New | Prolutex | |
| New | Rosalee | |
| New | Rosie | |
| New | Spikevax XBB.1.5 | |
| New | Supriad | |
| New | Tanilone | |
| New | Thyrox | |
| New | Vancomycin Juno | |
| New | Vyvanse (USA) | |
| Reinstated | Aripiprazole GH | |
| Reinstated | Arthrexin | |
| Revised | Aclasta | TGA Date |
| Revised | Act-HIB | Nature and Contents of Container |
| Revised | Adacel | Deleted Presentation, Dose and Method of Administration, Nature and Contents of Container |
| Revised | Alimta | TGA Date |
| Revised | Allertine | Pharmaceutical Form |
| Revised | Allosig | Sponsor |
| Revised | Alphaclav Duo Viatris, Alphaclav Duo Forte Viatris | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Alphagan | TGA Date |
| Revised | Alphagan P 1.5 | TGA Date |
| Revised | APO-Acamprosate | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
| Revised | APO-Azithromycin | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | APO-Candesartan | Qualitative and Quantitative Composition |
| Revised | APO-Carvedilol | Sponsor |
| Revised | APO-Escitalopram | Sponsor |
| Revised | APO-Frusemide | Sponsor |
| Revised | APO-Itraconazole | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
| Revised | APO-Metoprolol | Sponsor |
| Revised | APO-Olanzapine ODT | Adverse Effects (Undesirable Effects) |
| Revised | APO-Omeprazole | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | APO-Sertraline | Sponsor |
| Revised | Aropax | Special Warnings and Precautions for Use |
| Revised | ARX-Letrozole (was Letrozole APOTEX) | TGA Date |
| Revised | Augmentin Duo 400 Suspension | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Precautions for Storage |
| Revised | Augmentin Duo, Augmentin Duo Forte Tablets | Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Avaxim | TGA Date |
| Revised | Azith | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Azithromycin Mylan | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Azithromycin Viatris | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | B. Braun Midazolam | Adverse Effects (Undesirable Effects) |
| Revised | B. Braun Paracetamol | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
| Revised | Bendamustine Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Benlysta | Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Bijuva 1/100 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Blincyto | Dose and Method of Administration |
| Revised | Blooms the Chemist Candesartan | List of Excipients, Qualitative and Quantitative Composition |
| Revised | Blooms the Chemist Escitalopram | Sponsor |
| Revised | Bortezom | Dose and Method of Administration, List of Excipients, Special Precautions for Storage |
| Revised | Bridgewest Atropine Injection BP | Nature and Contents of Container, Pharmaceutical Form, Product Name change, Sponsor |
| Revised | Bridgewest Chlorhexidine and Cetrimide Irrigation Solution | List of Excipients, Nature and Contents of Container, Product Name change, Sponsor |
| Revised | Bridgewest Chlorhexidine Irrigation Solution | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Product Name change, Sponsor |
| Revised | Bridgewest Lidocaine Injection | List of Excipients, Product Name change, Sponsor |
| Revised | Bridgewest Metoclopramide Injection BP | Nature and Contents of Container, Pharmaceutical Form, Product Name change, Sponsor |
| Revised | Bridgewest Sodium Chloride 0.9% Irrigation Solution | Nature and Contents of Container, Product Name change, Sponsor |
| Revised | Bridgewest Sterile Potassium Chloride Concentrate | Deleted Presentation, List of Excipients, Nature and Contents of Container, Product Name change, Qualitative and Quantitative Composition, Sponsor |
| Revised | Bridgewest Water for Injection BP | Nature and Contents of Container, Product Name change, Sponsor |
| Revised | Brilinta | Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Brimica Genuair 340/12 | TGA Date |
| Revised | BTC Tamsulosin SR | Adverse Effects (Undesirable Effects) |
| Revised | Buprenorphine Sandoz | Dose and Method of Administration, Special Warnings and Precautions for Use |
| Revised | Cabenuva | Adverse Effects (Undesirable Effects), Dosage and Administration |
| Revised | Cabometyx | Adverse Effects (Undesirable Effects) |
| Revised | Candesan | TGA Date |
| Revised | Carbetocin Wockhardt | Adverse Effects (Undesirable Effects) |
| Revised | Carvedilol Sandoz | Adverse Effects (Undesirable Effects), Overdose |
| Revised | Carvidol | Sponsor |
| Revised | CellCept | Special Precautions for Storage |
| Revised | Clexane and Clexane Forte | TGA Date |
| Revised | ClinOleic 20% | Contraindications, Overdose, Special Warnings and Precautions for Use |
| Revised | Clobemix | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Cosentyx | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties |
| Revised | Crestor | Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Cymbalta | TGA Date |
| Revised | Cyramza | TGA Date |
| Revised | Darunavir Juno | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Dayvigo | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
| Revised | DBL Vincristine Sulfate Injection | Fertility, Pregnancy and Lactation, Pharmacological Properties |
| Revised | Desowen | TGA Date |
| Revised | Dexmedetomidine Viatris | Dose and Method of Administration, Product Name change, Shelf Life |
| Revised | Dicarz | Special Warnings and Precautions for Use |
| Revised | Dupixent | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition |
| Revised | Endone | Overdose |
| Revised | Enidin | TGA Date |
| Revised | Ephedrine Wockhardt | TGA Date |
| Revised | Estraderm MX | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Evelyn 150/30 ED | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Evista | Qualitative and Quantitative Composition |
| Revised | Ezecrest Composite Pack | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Flamazine | TGA Date |
| Revised | Flosix | Adverse Effects (Undesirable Effects) |
| Revised | Frusemix | Sponsor, Sponsor |
| Revised | Frusemix-M | Sponsor, Sponsor |
| Revised | Granisetron Kabi | TGA Date |
| Revised | Humalog U200 | TGA Date |
| Revised | Humalog, Humalog Mix25, Humalog Mix50 | TGA Date |
| Revised | Humulin Preparations | TGA Date |
| Revised | Hydralyte | Presentation |
| Revised | Hydromorphone JUNO/ JUNO-HP/ JUNO-XHP | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Hypnovel | Fertility, Pregnancy and Lactation |
| Revised | Ibupane | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Invanz | TGA Date |
| Revised | Inza | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication |
| Revised | Itracap | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
| Revised | Itranox | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
| Revised | Labetalol SXP | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Lanvis | Special Warnings and Precautions for Use |
| Revised | Lenest 30 ED | Dose and Method of Administration |
| Revised | Lescol XL | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Levemir | TGA Date |
| Revised | Libtayo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
| Revised | Lipex | Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Loxalate | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Lucrin Depot Paediatric Prefilled Dual Chamber Syringe (PDS) Injection 3 Month | Adverse Effects (Undesirable Effects), Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use, Special Warnings and Precautions for Use |
| Revised | Lucrin Depot Prefilled Dual Chamber Syringe (PDS) Injection | Adverse Effects (Undesirable Effects), Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use, Special Warnings and Precautions for Use |
| Revised | Maxor | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Medsurge Hydromorphone, HP | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Methoblastin | Adverse Effects (Undesirable Effects), Boxed Warnings, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | Methylene Blue Injection | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Methylphenidate XR ARX | TGA Date |
| Revised | Methylphenidate-Teva XR | TGA Date |
| Revised | Metvix | Qualitative and Quantitative Composition |
| Revised | Minax XL | List of Excipients, Nature and Contents of Container |
| Revised | Moclobemide Sandoz | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Myozyme | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Overdose |
| Revised | Neulactil | Qualitative and Quantitative Composition, Sponsor |
| Revised | Norditropin | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Noumed Diazepam | Qualitative and Quantitative Composition |
| Revised | NovoSeven RT | TGA Date |
| Revised | NovoThirteen | TGA Date |
| Revised | Orudis SR Capsules | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | Oruvail SR | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | Oxycodone Sandoz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use |
| Revised | Oxycodone Viatris | Overdose |
| Revised | Ozurdex | Adverse Effects (Undesirable Effects) |
| Revised | Pedea | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Penthrox Inhalation | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Nature and Contents of Container, Overdose, Special Warnings and Precautions for Use |
| Revised | Pfizer (Australia) Methotrexate Injection BP | Adverse Effects (Undesirable Effects), Boxed Warnings, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | Pfizer (Australia) Vincristine Sulfate | Fertility, Pregnancy and Lactation, Pharmacological Properties |
| Revised | Pharmacor Ezetimibe Rosuvastatin Composite Pack | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Pharmacor Ezetimibe Simvastatin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
| Revised | Pharmacor Rosuvastatin | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Pharmacy Choice Osteo Relief Paracetamol | TGA Date |
| Revised | Piax | Qualitative and Quantitative Composition |
| Revised | Plerixafor ARX | TGA Date |
| Revised | Precedex | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Precedex Ready to Use | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Prednefrin Forte | TGA Date |
| Revised | Prozac | Special Warnings and Precautions for Use |
| Revised | Pryzex ODT | Adverse Effects (Undesirable Effects) |
| Revised | Relpax | Nature and Contents of Container, Pharmaceutical Form |
| Revised | Rixalt | TGA Date |
| Revised | Rosuvastatin Lupin | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
| Revised | Salofalk Enemas | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Salofalk Foam | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
| Revised | Salofalk Granules | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
| Revised | Salofalk Suppositories | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | Salofalk Tablets | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | Sandrena | Nature and Contents of Container, Qualitative and Quantitative Composition |
| Revised | Scemblix | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Septrin Sugar Free Oral Liquid | TGA Date |
| Revised | Spedra | Nature and Contents of Container |
| Revised | Stromectol | TGA Date |
| Revised | Sulprix | Pharmaceutical Form |
| Revised | Tamsulosin Sandoz SR | Adverse Effects (Undesirable Effects) |
| Revised | Telfast | List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition, Therapeutic Indications |
| Revised | Temgesic | Qualitative and Quantitative Composition |
| Revised | Tibsovo | Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
| Revised | Tranexamic Acid LumaCina | Product Name change, Qualitative and Quantitative Composition, Sponsor |
| Revised | Trental 400 | Sponsor |
| Revised | Trientine Waymade | Special Precautions for Storage |
| Revised | Typhim Vi | TGA Date |
| Revised | Valpro EC | Sponsor, TGA Date |
| Revised | Vasodrine | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
| Revised | Vaxchora | TGA Date |
| Revised | Vaxigrip Tetra | Nature and Contents of Container |
| Revised | Velphoro | TGA Date |
| Revised | Venclexta | Adverse Effects (Undesirable Effects), Pharmacological Properties |
| Revised | Venofer | TGA Date |
| Revised | Victoza | TGA Date |
| Revised | Vocabria | Adverse Effects (Undesirable Effects) |
| Revised | Vosevi | TGA Date |
| Revised | Vytorin | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Vzole | List of Excipients, Nature and Contents of Container |
| Revised | Zeklen | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Zithro | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
| Revised | Zocor | Interactions with Other Medicines and Other Forms of Interactions |
| Revised | Zyloprim | Sponsor, TGA Date |
| Deleted | Acquin | |
| Deleted | APO-Quinapril | |
| Deleted | Diaformin XR | |
| Deleted | Eviplera | |
| Deleted | Gutron (NZ) | |
| Deleted | Harvoni | |
| Deleted | Omeprazole generichealth | |
| Deleted | Phenelzine Sulfate USP 15 mg Tablets (Lupin Pharmaceuticals) (Generic Health) | |
| Deleted | Primacor | |
| Deleted | Quinapril Generic Health | |
| Deleted | Sandoz Estradiol Derm (Canada) | |
| Deleted | Solicare ODT | |
| Deleted | Stribild | |
| Deleted | Telmisartan GH | |
| Deleted | Truvada | |
| Deleted | Tybost |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au